1.79000 EUR
0.01
0.56%
Last update Dec 12, 3:29 PM CET
Main market
Day range
1.79000
1.80000
Previous close
1.78000
Open
1.80000
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
1.79
0.01
0.56%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 5.3M 13.4M 17.0M 20.3M
Selling general and admin 11.5M 14.2M 27.3M 74.9M
Other operating expenses -1.0M 250K 20.6M
Operating income -15.8M -27.8M -44.3M -115.8M
Non operating interest income
Income 37.5K 494K 249K 0
Expense 195.9K 120K 0 18K
Other income expense -5.5M -2.7M 4.3M 22.8M
Pretax income -21.4M -30.2M -39.8M -93.1M
Tax provision 0 0
Net income -21.4M -30.2M -39.8M -93.1M
Basic EPS -2.4 -4 -6.1 -74.4
Diluted EPS -2.4 -4 -6.1 -74.4
Basic average shares 9.1M 8.2M 6.9M 4.9M
Diluted average shares 9.1M 8.2M 6.9M 4.9M
EBITDA -19.8M -30.0M -44.6M -115.8M
Net income from continuing op. -21.4M -30.2M -39.8M -93.1M
Minority interests
Preferred stock dividends 0 9K 0 255.8M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 13 hours 25 minutes

08:34
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).